Sight Sciences to Present at Citi's 2025 Unplugged MedTech and Life Sciences Access Day

Core Insights - Sight Sciences, Inc. is an eyecare technology company focused on developing innovative interventional technologies to transform care and improve patients' lives [1][3] - The company will present at Citi's 2025 Unplugged MedTech and Life Sciences Access Day on February 27, 2025 [2] Company Overview - Sight Sciences specializes in minimally invasive or non-invasive solutions targeting prevalent eye diseases, aiming to enhance patient care and replace outdated treatment methods [3] - The OMNI® Surgical System is designed for glaucoma surgery, indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma in the U.S. and CE Marked for specific procedures in Europe [3] - The SION® Surgical Instrument is a bladeless device for excising trabecular meshwork in ophthalmic surgeries [3] - The TearCare® System is cleared in the U.S. for localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction, addressing the leading cause of dry eye disease [3]